Research Article

Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C06 Status

Table 1

Disease features of the study population.

Feature: 400

Mean age, years (SD)
Mean age at psoriasis onset, years (SD).
Mean time of disease evolution, years (SD)
Men, (%)215 (53.8)
Women, (%)185 (46.2)
Mean PASI (SD)
, (%)280 (70)
, (%)120 (30)
Psoriasis family history, (%)168 (42)
, (%)160 (40)
Nail involvement, (%)240 (60)
PsA, (%)93 (23.3)
Mean waist circumference, cm (SD)
Mean BMI (SD)
Hypertension, (%)80 (20)
Dyslipidemia, (%)64 (16)
Obesity, (%)120 (30)
Smokers, (%)72 (18)
Diabetes, (%)42 (10.5)
CHD, (%)25 (6.3)
Total cholesterol, mg/dl (SD)
HDL-C, mg/dl (SD)
LDL-C, mg/dl (SD)
TG, mg/dl (SD)
Blood glucose, mg/dl (SD)
Topical/phototherapy treatment, (%)180 (45)
Nonbiologic systemic treatment, (%)248 (62%)
Biological therapy, (%)172 (43)

SD: standard deviation; : number; PASI: psoriasis area and severity index; PsA: psoriatic arthritis; BMI: body mass index; CHD: coronary heart disease; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglycerides.